MINDRAMP PODCAST - LIVE LONG, LIVE WELL

DEMENTIA: The FDA's Controversial Approval of Aduhelm

April 07, 2022 Michael C Patterson Season 2 Episode 5
MINDRAMP PODCAST - LIVE LONG, LIVE WELL
DEMENTIA: The FDA's Controversial Approval of Aduhelm
Show Notes

The FDA recently approved the first new drug for Alzheimer's in the last 18 years. .   Why are we not celebrating? Because there  are a slew of concerns about the approval decision. Ten out of eleven members of an independent review board voted against approval. The eleventh couldn't decide.  At least three of these reviewer have resigned in protest. In this podcast I review four of the main concerns about the FDA approval of Aduhelm.